Condition: Inflammatory Bowel Diseases · Crohn's Disease · Sponsor: Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)
This is a Phase 2, randomized, double-blind, placebo-controlled, multicenter study to evaluate the efficacy and safety of 3 active dose regimens of MORF-057 in adult study participants with moderately to severely active Crohn's disease (CD).
This description comes directly from the study's public registry record.
Trial questions or participation questions: 1-877-CTLILLY (1-877-285-4559) or · 1-317-615-4559 · LillyTrials@Lilly.com
Physicians interested in becoming principal investigators please contact · clinical_inquiry_hub@lilly.com
Always discuss trial participation with your own doctor first.
| Gastro Care Institute | Lancaster, California, United States | Recruiting |
| Infinity Clinical Research | San Diego, California, United States | Not Yet Recruiting |
| Peak Gastroenterology Associates - Colorado Springs | Colorado Springs, Colorado, United States | Recruiting |
| Clinical Research of Osceola | Kissimmee, Florida, United States | Recruiting |
| Bioresearch Partner-Kendale Lakes | Miami, Florida, United States | Not Yet Recruiting |
| Endoscopic Research Inc | Orlando, Florida, United States | Not Yet Recruiting |
| Tropical Clinical Trials | Palmetto Bay, Florida, United States | Not Yet Recruiting |
| Atlanta Gastroenterology Specialists, PC | Atlanta, Georgia, United States | Recruiting |
| Atlanta Gastroenterology Associates (Part of United Digestive) | Atlanta, Georgia, United States | Not Yet Recruiting |
| Tandem Clinical Research | Houma, Louisiana, United States | Recruiting |
| SSM Health DePaul Hospital- St. Louis | Bridgeton, Missouri, United States | Not Yet Recruiting |
| Las Vegas Clinical Trials | North Las Vegas, Nevada, United States | Not Yet Recruiting |
+ 213 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06226883